Could a simple injection cut opioid use after lung surgery?
NCT ID NCT05521789
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study tests whether injecting a numbing medicine (bupivacaine) near the spine can reduce pain and the need for opioid painkillers after lung surgery. Researchers will track pain scores and medication use in 70 adults undergoing lung tumor removal. The goal is to find a safer, more effective way to manage post-surgical pain.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- bupivacaine
- What this could lead to
- If it works, this could offer a better way to manage pain after lung surgery, reducing the need for strong painkillers.
- What could go wrong
- This is a small, early-phase study (70 people) testing a well-known drug for a new use. The results may not apply to all patients or surgeries.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PULMONARY CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The George Washington University
RECRUITINGWashington D.C., District of Columbia, 20037, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can an immunotherapy cocktail shrink inoperable lung tumors?
- New care model aims to close cancer treatment gaps for people with mental illness
- Rare cancer in pregnancy: global registry aims to fill knowledge gap
- Could everyday heart drugs shield cancer patients from Radiation's cardiac toll?
- AI boosts radiologist speed in reading chest scans
- New study aims to predict survival in respiratory care units